- Home
- HUMAW vs ATLC Comparison
HUMAW vs ATLC Comparison
Compare HUMAW & ATLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMAW
- ATLC
- Stock Information
- Founded
- HUMAW 2004
- ATLC 1996
- Country
- HUMAW United States
- ATLC United States
- Employees
- HUMAW N/A
- ATLC N/A
- Industry
- HUMAW Biotechnology: Pharmaceutical Preparations
- ATLC Finance: Consumer Services
- Sector
- HUMAW Health Care
- ATLC Finance
- Exchange
- HUMAW Nasdaq
- ATLC Nasdaq
- Market Cap
- HUMAW N/A
- ATLC N/A
- IPO Year
- HUMAW N/A
- ATLC 1999
- Fundamental
- Price
- HUMAW $1.09
- ATLC $57.27
- Analyst Decision
- HUMAW
- ATLC Strong Buy
- Analyst Count
- HUMAW 0
- ATLC 5
- Target Price
- HUMAW N/A
- ATLC $57.20
- AVG Volume (30 Days)
- HUMAW 14.2K
- ATLC 62.9K
- Earning Date
- HUMAW 03-21-2025
- ATLC 03-03-2025
- Dividend Yield
- HUMAW N/A
- ATLC N/A
- EPS Growth
- HUMAW N/A
- ATLC 8.45
- EPS
- HUMAW N/A
- ATLC 4.45
- Revenue
- HUMAW N/A
- ATLC $374,090,000.00
- Revenue This Year
- HUMAW N/A
- ATLC N/A
- Revenue Next Year
- HUMAW N/A
- ATLC $12.99
- P/E Ratio
- HUMAW N/A
- ATLC $12.87
- Revenue Growth
- HUMAW N/A
- ATLC 8.50
- 52 Week Low
- HUMAW $1.18
- ATLC $23.10
- 52 Week High
- HUMAW $1.34
- ATLC $64.70
- Technical
- Relative Strength Index (RSI)
- HUMAW N/A
- ATLC 45.78
- Support Level
- HUMAW N/A
- ATLC $57.40
- Resistance Level
- HUMAW N/A
- ATLC $63.00
- Average True Range (ATR)
- HUMAW 0.00
- ATLC 2.26
- MACD
- HUMAW 0.00
- ATLC -0.01
- Stochastic Oscillator
- HUMAW 0.00
- ATLC 25.58
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.